-
Wed02Sep2026Fri04Sep2026
-
Wed30Sep2026Sun04Oct2026
-
Wed30Sep2026Sun04Oct2026
-
Wed07Oct2026Fri09Oct2026
-
Sun11Oct2026Thu15Oct2026
-
Mon12Oct2026Fri16Oct2026
-
Wed21Oct2026Fri23Oct2026
-
Thu29Oct2026
Latest News
WallabyPhenox announces first patient enrolment in new study evaluating MeVO stroke...
WallabyPhenox has today announced that the first patient has been enrolled in PROMISE—an investigator-initiated, prospective study examining how medium-vessel occlusion (MeVO) acute ischaemic strokes...
Features
Why mechanical angioplasty deserves a place in the vasospasm treatment algorithm
As part of a PhD programme supervised by Boris Lubicz, Adrien Guenego (both Brussels, Belgium) recently conducted the first prospective randomised trial directly evaluating...
Who funds stroke trials in Europe—and why this matters more than...
Following the release of new findings from a survey conducted by the European Stroke Organisation Trials Alliance (ESOTA) on how clinical trials in stroke...
Videos
In part two of our special focus on CREST-2, William Gray (Main Line Health, Philadelphia, USA) is once again joined in the CX Studio by Sonya Noor (Buffalo Endovascular and Vascular Surgical Associates, Buffalo, USA) and Richard Bulbulia (University...
